Personal information

Other IDs

Scopus Author ID: 7004271201

Activities

Collapse all

Employment (6)

University of Sheffield: Sheffield, Sheffield, GB

2005-01 to present (Oncology and Metabolism )
Employment
Source: Self-asserted source
Timothy Skerry

Royal Veterinary College: London, London, GB

2001-10 to 2004-12 (Basic sciences)
Employment
Source: Self-asserted source
Timothy Skerry

University of York: York, York, GB

1995-10 to 2001-09 (Biology)
Employment
Source: Self-asserted source
Timothy Skerry

University of Bristol: Bristol, Bristol, GB

1989-04 to 1995-09 | lecturer (Anatomy)
Employment
Source: Self-asserted source
Timothy Skerry

University of Bristol: Bristol, Bristol, GB

1987-10 to 1989-03 (Veterinary Surgery)
Employment
Source: Self-asserted source
Timothy Skerry

Royal Veterinary College: London, London, GB

1984-10 to 1987-09 | PhD student (Anatomy)
Employment
Source: Self-asserted source
Timothy Skerry

Education and qualifications (2)

Royal Veterinary COllege/Kennedy Institute : London, GB

1984-10 to 1987-10 | PhD (Basic Sciences/Cell Biology)
Education
Source: Self-asserted source
Timothy Skerry

Royal Veterinary College: London, London, GB

1975-10 to 1980-04 | B.Vet. Med.
Education
Source: Self-asserted source
Timothy Skerry

Funding (7)

Development of novel antagonists of the cell surface adrenomedullin 2 receptor for the treatment of pancreatic cancer

Source: Self-asserted source
Timothy Skerry via DimensionsWizard

Development of selective Adrenomedullin-2 receptor antagonists for the treatment of pancreatic cancer

Source: Self-asserted source
Timothy Skerry via DimensionsWizard

Development of novel antagonists of the cell surface adrenomedullin 2 receptor for the treatment of pancreatic cancer

Source: Self-asserted source
Timothy Skerry via DimensionsWizard

Development of novel antagonists of the cell surface adrenomedullin 2 receptor for the treatment of pancreatic cancer

Source: Self-asserted source
Timothy Skerry via DimensionsWizard

Development of novel antagonists of the cell surface adrenomedullin 2 receptor for the treatment of pancreatic cancer

Source: Self-asserted source
Timothy Skerry via DimensionsWizard

Modelling complex and partially identified engineering problems- Application to the individualised multiscale simulation of the musculoskeletal system

Source: Self-asserted source
Timothy Skerry via DimensionsWizard

Role of Receptor Activity Modifying Protein-3 in regulation of lysyl oxidase-2 during tumour metastasis

Source: Self-asserted source
Timothy Skerry via DimensionsWizard
How many people are using ORCID?